Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Italy Predictive Genetic Testing Consumer Wellness Genomics Market

ID: MRFR/LS/50122-HCR
200 Pages
Satyendra Maurya
Last Updated: March 28, 2026

Italy Predictive Genetic Testing and Consumer Wellness Genomics Market Research Report By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, Others), and By Setting Type (Proteomic Testing, Metabolic Testing, Genomic Testing) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Italy Predictive Genetic Testing Consumer Wellness Genomics Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Health Risk Assessment
  50.     4.1.2 Carrier Testing
  51.     4.1.3 Ancestry Testing
  52.     4.1.4 Nutrigenomics
  53.     4.1.5 Pharmacogenomics
  54.   4.2 Healthcare, BY End Use (USD Million)
  55.     4.2.1 Healthcare Providers
  56.     4.2.2 Direct-to-Consumer
  57.     4.2.3 Research Institutions
  58.     4.2.4 Wellness Centers
  59.   4.3 Healthcare, BY Technology (USD Million)
  60.     4.3.1 Next Generation Sequencing
  61.     4.3.2 Microarray Technology
  62.     4.3.3 Sanger Sequencing
  63.     4.3.4 PCR Technology
  64.   4.4 Healthcare, BY Test Type (USD Million)
  65.     4.4.1 Whole Genome Sequencing
  66.     4.4.2 Exome Sequencing
  67.     4.4.3 Targeted Gene Panels
  68.     4.4.4 Single Nucleotide Polymorphism Testing
  69.   4.5 Healthcare, BY Consumer Demographics (USD Million)
  70.     4.5.1 Age Group
  71.     4.5.2 Income Level
  72.     4.5.3 Education Level
  73.     4.5.4 Health Consciousness
  74. 5 SECTION V: COMPETITIVE ANALYSIS
  75.   5.1 Competitive Landscape
  76.     5.1.1 Overview
  77.     5.1.2 Competitive Analysis
  78.     5.1.3 Market share Analysis
  79.     5.1.4 Major Growth Strategy in the Healthcare
  80.     5.1.5 Competitive Benchmarking
  81.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  82.     5.1.7 Key developments and growth strategies
  83.       5.1.7.1 New Product Launch/Service Deployment
  84.       5.1.7.2 Merger & Acquisitions
  85.       5.1.7.3 Joint Ventures
  86.     5.1.8 Major Players Financial Matrix
  87.       5.1.8.1 Sales and Operating Income
  88.       5.1.8.2 Major Players R&D Expenditure. 2023
  89.   5.2 Company Profiles
  90.     5.2.1 23andMe (US)
  91.       5.2.1.1 Financial Overview
  92.       5.2.1.2 Products Offered
  93.       5.2.1.3 Key Developments
  94.       5.2.1.4 SWOT Analysis
  95.       5.2.1.5 Key Strategies
  96.     5.2.2 MyHeritage (IL)
  97.       5.2.2.1 Financial Overview
  98.       5.2.2.2 Products Offered
  99.       5.2.2.3 Key Developments
  100.       5.2.2.4 SWOT Analysis
  101.       5.2.2.5 Key Strategies
  102.     5.2.3 Ancestry (US)
  103.       5.2.3.1 Financial Overview
  104.       5.2.3.2 Products Offered
  105.       5.2.3.3 Key Developments
  106.       5.2.3.4 SWOT Analysis
  107.       5.2.3.5 Key Strategies
  108.     5.2.4 Genetic Health (IT)
  109.       5.2.4.1 Financial Overview
  110.       5.2.4.2 Products Offered
  111.       5.2.4.3 Key Developments
  112.       5.2.4.4 SWOT Analysis
  113.       5.2.4.5 Key Strategies
  114.     5.2.5 DnaNudge (GB)
  115.       5.2.5.1 Financial Overview
  116.       5.2.5.2 Products Offered
  117.       5.2.5.3 Key Developments
  118.       5.2.5.4 SWOT Analysis
  119.       5.2.5.5 Key Strategies
  120.     5.2.6 Genomics England (GB)
  121.       5.2.6.1 Financial Overview
  122.       5.2.6.2 Products Offered
  123.       5.2.6.3 Key Developments
  124.       5.2.6.4 SWOT Analysis
  125.       5.2.6.5 Key Strategies
  126.     5.2.7 Invitae (US)
  127.       5.2.7.1 Financial Overview
  128.       5.2.7.2 Products Offered
  129.       5.2.7.3 Key Developments
  130.       5.2.7.4 SWOT Analysis
  131.       5.2.7.5 Key Strategies
  132.     5.2.8 Fulgent Genetics (US)
  133.       5.2.8.1 Financial Overview
  134.       5.2.8.2 Products Offered
  135.       5.2.8.3 Key Developments
  136.       5.2.8.4 SWOT Analysis
  137.       5.2.8.5 Key Strategies
  138.   5.3 Appendix
  139.     5.3.1 References
  140.     5.3.2 Related Reports
  141. 6 LIST OF FIGURES
  142.   6.1 MARKET SYNOPSIS
  143.   6.2 ITALY MARKET ANALYSIS BY APPLICATION
  144.   6.3 ITALY MARKET ANALYSIS BY END USE
  145.   6.4 ITALY MARKET ANALYSIS BY TECHNOLOGY
  146.   6.5 ITALY MARKET ANALYSIS BY TEST TYPE
  147.   6.6 ITALY MARKET ANALYSIS BY CONSUMER DEMOGRAPHICS
  148.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  149.   6.8 RESEARCH PROCESS OF MRFR
  150.   6.9 DRO ANALYSIS OF HEALTHCARE
  151.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  152.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  153.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  154.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  155.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  156.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  157.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  158.   6.17 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  159.   6.18 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  160.   6.19 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
  161.   6.20 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Million)
  162.   6.21 HEALTHCARE, BY CONSUMER DEMOGRAPHICS, 2024 (% SHARE)
  163.   6.22 HEALTHCARE, BY CONSUMER DEMOGRAPHICS, 2024 TO 2035 (USD Million)
  164.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  165. 7 LIST OF TABLES
  166.   7.1 LIST OF ASSUMPTIONS
  167.     7.1.1
  168.   7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  169.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  170.     7.2.2 BY END USE, 2026-2035 (USD Million)
  171.     7.2.3 BY TECHNOLOGY, 2026-2035 (USD Million)
  172.     7.2.4 BY TEST TYPE, 2026-2035 (USD Million)
  173.     7.2.5 BY CONSUMER DEMOGRAPHICS, 2026-2035 (USD Million)
  174.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  175.     7.3.1
  176.   7.4 ACQUISITION/PARTNERSHIP
  177.     7.4.1

Italy Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Health Risk Assessment
  • Carrier Testing
  • Ancestry Testing
  • Nutrigenomics
  • Pharmacogenomics

Healthcare By End Use (USD Million, 2026-2035)

  • Healthcare Providers
  • Direct-to-Consumer
  • Research Institutions
  • Wellness Centers

Healthcare By Technology (USD Million, 2026-2035)

  • Next Generation Sequencing
  • Microarray Technology
  • Sanger Sequencing
  • PCR Technology

Healthcare By Test Type (USD Million, 2026-2035)

  • Whole Genome Sequencing
  • Exome Sequencing
  • Targeted Gene Panels
  • Single Nucleotide Polymorphism Testing

Healthcare By Consumer Demographics (USD Million, 2026-2035)

  • Age Group
  • Income Level
  • Education Level
  • Health Consciousness

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓